Researchers investigated the association of NSAID use with the development of incident hypertension in a cohort of patients with ankylosing spondylitis.
Researchers investigated the risk for immune-mediated inflammatory diseases in patients with ankylosing spondylitis.
Researchers conducted this study to determine whether bone bridge formation was correlated with low bone mineral density in patients with ankylosing spondylitis.
This study aimed to provide an estimate of depression prevalence among patients with ankylosing spondylitis vs those without ankylosing spondylitis.
The ASAS MRI working group created a consensus update on standardized definitions for MRI lesions in the sacroiliac joint of patients with spondyloarthritis and to perform preliminary validation.
Investigators reviewed drug retention and response rates in patients with axial spondyloarthritis after their first initiation with tumor necrosis factor inhibitors.
Based on new evidence and an expert consensus, the American College of Rheumatology (ACR), the Spondylitis Association of America, and the Spondyloarthritis Research and Treatment Network released updated recommendations for the treatment of axial spondyloarthritis (SpA), which comprises ankylosing spondylitis (AS) and nonradiographic axial SpA. This report was published in Arthritis Care & Research. A systematic…
Researchers examined the effects of HLA-B27 and HLA-DRB1 alleles on the intestinal microbiome of healthy individuals.
Updated recommendations for the treatment of ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis were presented.
The FDA has approved Taltz (ixekizumab; Eli Lilly) for the treatment of adults with active ankylosing spondylitis (AS), also known as radiographic axial spondyloarthritis.